Stock A302440 SK BIOSCIENCE CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company SK bioscience Co.,Ltd.

Equities

A302440

KR7302440003

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
57,400 KRW -0.17% Intraday chart for SK bioscience Co.,Ltd. -1.37% -20.28%
Mar. 28 SK Bioscience Signs Deal with Sanofi for Five Vaccine Types MT
Mar. 07 SK Bioscience Breaks Ground on Manufacturing Facility Expansion for Extending Product Pipeline CI

Business Summary

SK Bioscience Co Ltd is a Korea-based company mainly engaged in the manufacture and sale of biological products. The Company's main products include vaccines such as SKYCellflu and Rotatech. The Company also sells infusion solutions. In addition, the Company engages in technology export business. The Company sells its products in domestic and overseas markets.

Sales per Business

KRW in Million2022Weight2023Weight Delta
Vaccine/Biopharmaceuticals
100.0 %
456,726 100.0 % 369,506 100.0 % -19.10%

Sales per region

KRW in Million2022Weight2023Weight Delta
America
50.3 %
217,834 47.7 % 185,961 50.3 % -14.63%
South Korea
42.8 %
224,157 49.1 % 158,217 42.8 % -29.42%
Europe
5.7 %
13,778 3.0 % 21,202 5.7 % +53.88%
Asia
1.1 %
651 0.1 % 3,893 1.1 % +497.76%
Middle East
0.1 %
305 0.1 % 232 0.1 % -24.07%

Managers

Managers TitleAgeSince
Jae-Yong An CEO
 Chief Executive Officer 56 -
Yong-Sung Choi DFI
 Director of Finance/CFO 51 -
Sally Choe CTO
 Chief Tech/Sci/R&D Officer - -
Jong-Gu Park CTO
 Chief Tech/Sci/R&D Officer 59 -
Hun Kim CTO
 Chief Tech/Sci/R&D Officer 57 17-12-31
Young-Joo Park IRC
 Investor Relations Contact 54 -
Harry Kleanthous PRN
 Corporate Officer/Principal - 22-10-20
Ji-Hyun Yoo LAW
 General Counsel 46 -
Su-Ahn Yoo SAM
 Sales & Marketing 51 -

Members of the board

Members of the board TitleAgeSince
Jeffrey Choi BRD
 Director/Board Member 60 -
Chang-Jin Moon BRD
 Director/Board Member 71 -
Jae-Yong An CEO
 Chief Executive Officer 56 -
Mi-Jin Cho BRD
 Director/Board Member 62 -
Gwang-Hyun Jeon BRD
 Director/Board Member 59 -
Hun Kim CTO
 Chief Tech/Sci/R&D Officer 57 17-12-31
Ik-Hwan Kwon BRD
 Director/Board Member 57 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 76,827,750 24,186,505 ( 31.48 %) 0 31.48 %

Shareholders

NameEquities%Valuation
SK CHEMICALS CO.,LTD
67.76 %
52,059,724 67.76 % 2 370 M ₩
SK bioscience Co., Ltd. ESOA
0.6769 %
520,059 0.6769 % 24 M ₩
Sjunde AP-fonden
0.0716 %
55,003 0.0716 % 3 M ₩
State Street Global Advisors Ltd.
0.0569 %
43,689 0.0569 % 2 M ₩
Northern Trust Fund Managers (Ireland) Ltd.
0.0384 %
29,489 0.0384 % 1 M ₩
Mercer Global Investments Europe Ltd.
0.0219 %
16,853 0.0219 % 767 383 ₩
Korea Investment Management Co., Ltd.
0.0164 %
12,622 0.0164 % 574 729 ₩
Universal-Investment-Gesellschaft mbH (Invt Mgmt)
0.0125 %
9,630 0.0125 % 438 491 ₩
Irish Life Investment Managers Ltd.
0.0102 %
7,862 0.0102 % 357 987 ₩
abrdn Alternative Investments Ltd.
0.009445 %
7,256 0.009445 % 330 394 ₩

Holdings

NameEquities%Valuation
NOVAVAX, INC.
4.64%
 6,500,000 4.64% 31,070,000 $

Company contact information

SK bioscience Co., Ltd.

310 Pangyo-ro Bundang-gu

13494, Seongnam-si

+82 2 2008 2200

http://www.skbioscience.co.kr
address SK bioscience Co.,Ltd.(A302440)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per region

Ratings for SK bioscience Co.,Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
8
Last Close Price
57,400 KRW
Average target price
58,000 KRW
Spread / Average Target
+1.05%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Biopharmaceuticals

1st Jan change Capi.
SK BIOSCIENCE CO.,LTD. Stock SK bioscience Co.,Ltd.
-20.28% 3.22B
CSL LIMITED Stock CSL Limited
-4.66% 87.53B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+1.32% 40.42B
BIOGEN INC. Stock Biogen Inc.
-19.27% 29.48B
UCB Stock UCB
+57.86% 25.43B
INCYTE CORPORATION Stock Incyte Corporation
-17.82% 11.49B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-43.00% 11.3B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-9.14% 11.1B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+5.24% 8.75B
INNOVENT BIOLOGICS, INC. Stock Innovent Biologics, Inc.
-8.42% 7.99B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. A302440 Stock
  4. Company SK bioscience Co.,Ltd.